Clinical trial

Serplulimab Monotherapy in Elderly Patients With NSCLC and PD-L1 TPS ≥ 50%

NCT07596121

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-05-13

PhasePHASE2

Study timeline

Study start (actual)2026-05-13Date precision: day

Registry last updated2026-05-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

NSCLC (Non-small Cell Lung Cancer)unresolved

Interventions

SerplulimabDRUG

Sponsors & collaborators

Tang-Du Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07596121 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.